<DOC>
	<DOCNO>NCT01033058</DOCNO>
	<brief_summary>This retrospective , randomize , parallel , open-labeled , control study find whether STEMI patient undergo emergency PCI benefit intensive atorvastatin treatment compare routine treatment .</brief_summary>
	<brief_title>Intensive Statin Treatment STEMI Patients Undergoing Primary PCI</brief_title>
	<detailed_description>ARMYDA-ACS , ARMYDA-RECAPTURE NAPLES II demonstrate patient ASP NSTE ACS undergo early PCI , load dose atorvastatin early PCI lead reduction prei-PCI MI , recurrent CV event mortality . While , theses study include patient non-ST-segment elevation ACS , require PCI ; result extrapolate directly patient ST-segment elevation MI , trial include patient send early selective PCI , undergo emergency revascularization ; This study design find whether STEMI patient undergo emergency PCI benefit intensive atorvastatin treatment compare routine treatment .</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>2075 year old myocardiac ischemia symptom index event appear less 12 hour enrollment . ECG show elevate ST segment 3 contiguous lead diagnose acute STEMI eligible primary PCI , primary PCI schedule within 2 hour enrollment allergic experience serious adverse reaction HMGCoA reductase pregnancy , lactation , child bear potential woman without effective contraception accompany malignant disease active hepatic disease hepatic dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>STEMI</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>PCI</keyword>
</DOC>